BAI Yuelan, JI Jun, HE Shenghu. Relationship between serum cystatin C and coronary heart disease and its severity in female patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 51-55. DOI: 10.7619/jcmp.202003015
Citation: BAI Yuelan, JI Jun, HE Shenghu. Relationship between serum cystatin C and coronary heart disease and its severity in female patients[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 51-55. DOI: 10.7619/jcmp.202003015

Relationship between serum cystatin C and coronary heart disease and its severity in female patients

More Information
  • Received Date: November 10, 2019
  • Objective To explore the clinical value of serum cystatin C in prediction of coronary heart disease and its severity in female patients. Methods Through the hospital electronic medical record system, totally 90 patients with coronary heart disease confirmed by coronary angiography were selected as coronary heart disease group, and 90 patients with non-coronary heart disease were selected as non-coronary heart disease group. The coronary heart disease group was divided into acute coronary syndrome group(n=58)and chronic coronary disease group(n=32)according to types of attack, and was also divided into male group and female group according to gender. According to the Gensini score, the patients in the acute coronary syndrome group were divided into high-risk group(more than 80 points, n=22), medium-risk group(50 to 80 points, n=18)and low-risk group(less than 50 points, n=18). According to the different levels of serum cystatin C in different groups, the relationship between serum cystatin C and coronary heart disease and its severity was evaluated. Results The level of cystatin C in the coronary heart disease group was significantly higher than that in the non-coronary heart disease group(P < 0.05), and the level of cystatin C in female patients with coronary heart disease was significantly higher than that in female patients(P < 0.05). In the non-coronary heart disease group, there was no significant difference in serum cystatin C between male and female patients(P > 0.05). The level of cystatin C in the acute coronary group was significantly higher - than that in the chronic coronary artery disease group(P < 0.05), and the level of cystatin C in female patients was significantly higher than that in male patients(P < 0.05). The level of cystatin C in the high-risk group based on Gensini score evaluation was significantly higher than that in the medium-risk and low-risk group(P < 0.05), and that in the medium-risk group was significantly higher than low-risk group(P < 0.05). There was a positive correlation between Gensini score and cystatin C level(P < 0.01). Conclusion Cystatin C can be used as an important indicator for prediction of the severity of coronary heart disease. At the same time, serum cystatin C level in women is higher than men, and Gensini score is positively correlated with cystatin C level.
  • 任加以, 何贵新, 秦伟彬, 等. 经皮冠状动脉介入术后心肌缺血再灌注损伤的药物治疗与预防进展[J]. 广西医学, 2018, 40(18): 2187-2190

    , 2197.
    宋宁, 杨毅宁. 长链非编码RNA与冠心病发生发展关系的研究进展[J]. 心血管病学进展, 2016, 37(5): 529-532.
    王存富, 潘闽. 血清胱抑素C水平在无慢性肾脏病的冠心病患者中的临床价值研究[J]. 临床和实验医学杂志, 2017, 16(4): 329-333.
    符武岛, 李伟, 曾敏, 等. 血清胱抑素C水平与女性无慢性肾脏疾病患者冠状动脉钙化的相关性探讨[J]. 临床心血管病杂志, 2019, 35(5): 425-429.
    Abaci O, Kocas C, Oktay V, et al. Relationship between myocardial performance index and severity of coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome[J]. Cardiovasc J Afr, 2017, 28(1): 4-7.
    Arbab-Zadeh A, Fuster V. The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography[J]. J Am Coll Cardiol, 2016, 68(22): 2467-2478.
    庄德荣, 何胜虎, 蔡定华, 等. hs-CRP、D-二聚体和Lp-PLA2与冠心病患者冠状动脉粥样硬化易损斑块的相关性[J]. 现代生物医学进展, 2017, 17(26): 5131-5133.
    阿丽米拉·赛依提江, 邢智, 佴志慧, 等. 冠心病患者血小板体积分布宽度、胱抑素C与冠脉病变严重程度的关系[J]. 新疆医科大学学报, 2018, 41(10): 1202-1205

    , 1209.
    崔寒英. 冠心病患者血清超敏C-反应蛋白、胱抑素C水平变化的意义分析[J]. 河北医药, 2016, 38(12): 1771-1775.
    Zhang J J, Wu X H, Gao P Z, et al. Correlations of serum cystatin C and glomerular filtration rate with vascular lesions and severity in acute coronary syndrome[J]. BMC Cardiovasc Disord, 2017, 17(1): 47-50.
    王晓艳, 王留义, 何姗姗, 等. 冠状动脉粥样硬化性心脏病患者高密度脂蛋白胆固醇水平及冠状动脉病变程度与血管内皮功能的相关性研究[J]. 中国医药, 2017, 12(2): 182-186.
    王聪霞, 范雅洁. 冠心病血管内皮损伤与血管重构的研究进展[J]. 西安交通大学学报: 医学版, 2018, 39(4): 455-458.
    王森, 张毅刚. 血清胱抑素C在心血管疾病中的研究进展[J]. 安徽医药, 2016, 20(6): 1030-1034.
    齐玉彦, 张淑岩, 沈鹏, 等. 胱抑素C与缺血性脑血管病的研究进展[J]. 卒中与神经疾病, 2018, 25(3): 329-331.
    朱晓平, 罗文强, 南方, 等. 胱抑素C、血脂及血糖联合检测对动脉粥样硬化患者的诊断价值[J]. 陕西医学杂志, 2017, 46(9): 1293-1295

    , 1317.
    Toshiyuki Kobayashi, Hirohide Yokokawa, Kazutoshi Fujibayashi, et al. Association between high cystatin C levels and carotid atherosclerosis[J]. World J Cardiol, 2017, 9(2): 174-181.
    刘海伟, 韩雅玲, 马颖艳, 等. 2 303例女性冠心病患者临床表现及冠状动脉造影病变特点的相关性分析[J]. 医学与哲学: B, 2013, 34(9

    ): 35-37, 49.
    Clegg D, Hevener A L, Moreau K L, et al. Sex hormones and cardiometabolic health: role of estrogen and estrogen receptors[J]. Endocrinology, 2017, 158(5): 1095-1105.
    Regitz-Zagrosek V. Unsettled issues and future directions for research on cardiovascular diseases in women[J]. Korean Circ J, 2018, 48(9): 792-812.
    Sugiyama H, Miyoshi T, Osawa K, et al. Serum cystatin C levels are associated with coronary artery calcification in women without chronic kidney disease[J]. J Cardiol, 2017, 70(6): 559-564.
    徐志强, 周赟, 王骏. 胱抑素Crs1064039位点单核苷酸基因多态性与冠心病的相关性研究[J]. 临床心血管病杂志, 2015, 31(2): 152-155.
    任朋, 许邦龙. 绝经女性胱抑素C与冠心病的相关性研究[J]. 安徽医药, 2016, 20(3): 492-495.
    薛刚. 冠心病患者血清超敏C反应蛋白及胱抑素C水平检测的临床意义[J]. 中国保健营养, 2016, 26(9): 369-370.
    沈云峰, 胡远贵, 张洪波, 等. 冠心病患者血清胱抑素C、一氧化氮、超氧化物歧化酶及超敏C反应蛋白水平变化及与冠脉狭窄程度的相关性[J]. 微循环学杂志, 2014, 24(3): 28-31.
    王晶. 红细胞分布宽度、胱抑素-C及颈动脉内中膜厚度与冠状动脉病变程度的相关性研究[D]. 太原: 山西医科大学, 2015.
    任朋. 绝经女性血清胱抑素C与冠心病的相关性研究[D]. 合肥: 安徽医科大学, 2016.
    张春阳. 红细胞分布宽度、血小板体积分布宽度及血清胱抑素-C与冠状动脉病变程度的相关性研究[D]. 太原: 山西医科大学, 2014.
    蔡雪清. 血清胱抑素C值在妊娠期孕妇心功能的评估意义[J]. 现代诊断与治疗, 2016, 27(12): 2297-2299.

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return